Skip to main content

Alphabet Inc.'s Form 4 filing

Prime Medicine, Inc. (PRME) · filed Jun 7, 2023

Accession no.
0001209191-23-035068
Filed
Jun 7, 2023, 4:17 PM ET
Trade date
Jun 5-6, 2023
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $884.8K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Alphabet Inc.CIK 000165204410% Owner
GV 2019 GP, L.L.C.CIK 000184503810% Owner
GV 2019 GP, L.P.CIK 000184503910% Owner
GV 2019, L.P.CIK 000184504110% Owner
GV 2021, L.P.CIK 000186120210% Owner
GV 2021 GP, L.L.C.CIK 000186120610% Owner
GV 2021 GP, L.P.CIK 000186121610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 5, 2023Common StockJOtherDisposed−22,434$0.00$010,368,395Indirect
Jun 5, 2023Common StockSSaleDisposed−22,434$16.70−$374,611.910Indirect
Jun 6, 2023Common StockJOtherDisposed−29,975$0.00$010,338,420Indirect
Jun 6, 2023Common StockSSaleDisposed−29,975$17.02−$510,165.510Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)